Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry

dc.contributor.authorCrotti, Lia
dc.contributor.authorSpazzolini, Carla
dc.contributor.authorTester, David J
dc.contributor.authorGhidoni, Alice
dc.contributor.authorBaruteau, Alban-Elouen
dc.contributor.authorBeckmann, Britt-Maria
dc.contributor.authorBehr, Elijah R
dc.contributor.authorBennett, Jeffrey S
dc.contributor.authorBezzina, Connie R
dc.contributor.authorBhuiyan, Zahurul A
dc.contributor.authorCeliker, Alpay
dc.contributor.authorCerrone, Marina
dc.contributor.authorDagradi, Federica
dc.contributor.authorDe Ferrari, Gaetano M
dc.contributor.authorEtheridge, Susan P
dc.contributor.authorFatah, Meena
dc.contributor.authorGarcia-Pavia, Pablo
dc.contributor.authorAl-Ghamdi, Saleh
dc.contributor.authorHamilton, Robert M
dc.contributor.authorAl-Hassnan, Zuhair N
dc.contributor.authorHorie, Minoru
dc.contributor.authorJimenez-Jaimez, Juan
dc.contributor.authorKanter, Ronald J.
dc.contributor.authorKaski, Juan P.
dc.contributor.authorKotta, Maria-Christina
dc.contributor.authorLahrouchi, Najim
dc.contributor.authorMakita, Naomasa
dc.contributor.authorNorrish, Gabrielle
dc.contributor.authorOdland, Hans H.
dc.contributor.authorOhno, Seiko
dc.contributor.authorPapagiannis, John
dc.contributor.authorParati, Gianfranco
dc.contributor.authorSekarski, Nicole
dc.contributor.authorTveten, Kristian
dc.contributor.authorVatta, Matteo
dc.contributor.authorWebster, Gregory
dc.contributor.authorWilde, Arthur A. M.
dc.contributor.authorWojciak, Julianne
dc.contributor.authorGeorge, Alfred L., Jr
dc.contributor.authorAckerman, Michael J.
dc.contributor.authorSchwartz, Peter J.
dc.contributor.departmentMedical and Molecular Genetics, School of Medicineen_US
dc.date.accessioned2021-05-20T20:53:11Z
dc.date.available2021-05-20T20:53:11Z
dc.date.issued2016-06-06
dc.description.abstractAims Calmodulinopathies are rare life-threatening arrhythmia syndromes which affect mostly young individuals and are, caused by mutations in any of the three genes (CALM 1–3) that encode identical calmodulin proteins. We established the International Calmodulinopathy Registry (ICalmR) to understand the natural history, clinical features, and response to therapy of patients with a CALM-mediated arrhythmia syndrome. Methods and results A dedicated Case Report File was created to collect demographic, clinical, and genetic information. ICalmR has enrolled 74 subjects, with a variant in the CALM1 (n = 36), CALM2 (n = 23), or CALM3 (n = 15) genes. Sixty-four (86.5%) were symptomatic and the 10-year cumulative mortality was 27%. The two prevalent phenotypes are long QT syndrome (LQTS; CALM-LQTS, n = 36, 49%) and catecholaminergic polymorphic ventricular tachycardia (CPVT; CALM-CPVT, n = 21, 28%). CALM-LQTS patients have extremely prolonged QTc intervals (594 ± 73 ms), high prevalence (78%) of life-threatening arrhythmias with median age at onset of 1.5 years [interquartile range (IQR) 0.1–5.5 years] and poor response to therapies. Most electrocardiograms (ECGs) show late onset peaked T waves. All CALM-CPVT patients were symptomatic with median age of onset of 6.0 years (IQR 3.0–8.5 years). Basal ECG frequently shows prominent U waves. Other CALM-related phenotypes are idiopathic ventricular fibrillation (IVF, n = 7), sudden unexplained death (SUD, n = 4), overlapping features of CPVT/LQTS (n = 3), and predominant neurological phenotype (n = 1). Cardiac structural abnormalities and neurological features were present in 18 and 13 patients, respectively. Conclusion Calmodulinopathies are largely characterized by adrenergically-induced life-threatening arrhythmias. Available therapies are disquietingly insufficient, especially in CALM-LQTS. Combination therapy with drugs, sympathectomy, and devices should be considered.en_US
dc.identifier.citationCrotti, L., Spazzolini, C., Tester, D. J., Ghidoni, A., Baruteau, A.-E., Beckmann, B.-M., Behr, E. R., Bennett, J. S., Bezzina, C. R., Bhuiyan, Z. A., Celiker, A., Cerrone, M., Dagradi, F., De Ferrari, G. M., Etheridge, S. P., Fatah, M., Garcia-Pavia, P., Al-Ghamdi, S., Hamilton, R. M., … Schwartz, P. J. (2019). Calmodulin mutations and life-threatening cardiac arrhythmias: Insights from the International Calmodulinopathy Registry. European Heart Journal, 40(35), 2964–2975. https://doi.org/10.1093/eurheartj/ehz311en_US
dc.identifier.issn0195-668Xen_US
dc.identifier.urihttps://hdl.handle.net/1805/25978
dc.language.isoen_USen_US
dc.publisherOxford University Pressen_US
dc.relation.isversionof10.1093/eurheartj/ehz311en_US
dc.relation.journalEuropean Heart Journalen_US
dc.sourcePMCen_US
dc.subjectCalmodulinen_US
dc.subjectCathecolaminergic polymorphic ventricular tachycardiaen_US
dc.subjectIdiopathic ventricular fibrillationen_US
dc.subjectLong QT syndromeen_US
dc.subjectSudden deathen_US
dc.titleCalmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registryen_US
dc.typeArticleen_US
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748747/en_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ehz311.pdf
Size:
967.88 KB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: